Advertisement

In vitro drug release behavior of Ce-doped nano-bioactive glass carriers under oxidative stress

  • Mohammad M. FaragEmail author
  • Zainab M. Al-Rashidy
  • Manar M. Ahmed
Delivery Systems Original Research
  • 53 Downloads
Part of the following topical collections:
  1. Delivery Systems

Abstract

Ce-containing bioactive glasses are known to decrease reactive oxygen activities inside the body. That is because of their excellent catalytic activities which come from the fast interchange of Ce3+/Ce4+ oxidation states. This research was mainly aimed at preparing new Ce-doped nano-bioactive glasses based on 60SiO2-(10-x)B2O3-25CaO-5P2O5-xCeO2, in mole% (x = 0 and 5 mol%) as multifunctional bone fillings. Moreover, the glasses were used as a delivery system for ciprofloxacin to intensely solve the bone infection complications. Nevertheless, there were no previous works studied of the nature immersing solution effect on the drug release behavior from Ce-doped nano-bioactive glass carriers. Therefore, phosphate-free and phosphate-containing buffer solutions with/without superoxide species (H2O2) were used to investigate the efficacy of this drug delivery system in different environment. The results showed that Ce addition enhanced the formation of apatite layer and cell viability. Moreover, the percentage of released drug was apparently affected by the glass composition and nature of soaking fluid, specifically, in the media containing superoxide species (H2O2). In conclusion, the prepared Ce-doped glass nanoparticles illustrated multifunctional bone filling material, but when it intended to be utilized as a drug delivery system, the nature of surrounding medium have to be taken into consideration.

Notes

Acknowledgements

We would like to thank the National Research Center, Faculty of Science and Al-Azhar University (Girls), Egypt for a possibility to use their facilities.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Chen J, Patil S, Seal S, McGinnis JF. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol. 2006;1:142–50.CrossRefGoogle Scholar
  2. 2.
    Korsvik C, Patil S, Seal S, Self WT. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun. 2007;1056–8.  https://doi.org/10.1039/B615134E.
  3. 3.
    Pirmohamed T, Dowding JM, Singh S, Wasserman B, Heckert E, Karakoti AS, et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun. 2010;46:2736–8.CrossRefGoogle Scholar
  4. 4.
    Du J, Kokou L, Rygel JL, Chen Y, Pantano CG, Woodman R, et al. Structure of cerium phosphate glasses: molecular dynamics simulation. J Am Ceram Soc. 2011;94:2393–401.CrossRefGoogle Scholar
  5. 5.
    Leonelli C, Lusvardi G, Malavasi G, Menabue L, Tonelli M. Synthesis and characterization of cerium-doped glasses and in vitro evaluation of bioactivity. J Non-Cryst Solids. 2003;316:198–216.CrossRefGoogle Scholar
  6. 6.
    Goh Y-F, Alshemary AZ, Akram M, Kadir MRA, Hussain R. In-vitro characterization of antibacterial bioactive glass containing ceria. Ceram Int. 2014;40:729–37.CrossRefGoogle Scholar
  7. 7.
    Shruti S, Salinas AJ, Malavasi G, Lusvardi G, Menabue L, Ferrara C, et al. Structural and in vitro study of cerium, gallium and zinc containing sol–gel bioactive glasses. J Mater Chem. 2012;22:13698–706.CrossRefGoogle Scholar
  8. 8.
    Zhang J, Liu C, Li Y, Sun J, Wang P, Di K, et al. Effect of cerium ion on the proliferation, differentiation and mineralization function of primary mouse osteoblasts in vitro. J Rare Earths. 2010;28:138–42.CrossRefGoogle Scholar
  9. 9.
    Deliormanlı AM. Synthesis and characterization of cerium- and gallium-containing borate bioactive glass scaffolds for bone tissue engineering. J Mater Sci Mater Med. 2015;26:67.CrossRefGoogle Scholar
  10. 10.
    Gupta B, Papke JB, Mohammadkhah A, Day DE, Harkins AB. Effects of chemically doped bioactive borate glass on neuron regrowth and regeneration. Ann Biomed Eng. 2016;44:3468–77.CrossRefGoogle Scholar
  11. 11.
    Nicolini V, Malavasi G, Menabue L, Lusvardi G, Benedetti F, Valeri S, et al. Cerium-doped bioactive 45S5 glasses: spectroscopic, redox, bioactivity and biocatalytic properties. J Mater Sci. 2017;52:8845–57.CrossRefGoogle Scholar
  12. 12.
    Nicolini V, Varini E, Malavasi G, Menabue L, Menziani MC, Lusvardi G, et al. The effect of composition on structural, thermal, redox and bioactive properties of Ce-containing glasses. Mater Des. 2016;97:73–85.CrossRefGoogle Scholar
  13. 13.
    Placek L, Keenan T, Coughlan A, Wren A. Investigating the effect of glass ion release on the cytocompatibility, antibacterial eflcacy and antioxidant activity of Y2O3/CeO2 doped SiO2-SrO-Na2O glasses. Biomed Glass. 2018;4:32–44.CrossRefGoogle Scholar
  14. 14.
    Nicolini V, Gambuzzi E, Malavasi G, Menabue L, Menziani MC, Lusvardi G, et al. Evidence of catalase mimetic activity in Ce3+/Ce4+doped bioactive glasses. J Phys Chem B. 2015;119:4009–19.CrossRefGoogle Scholar
  15. 15.
    Devirian TA, Volpe SL. The physiological effects of dietary boron. Crit Rev Food Sci Nutr. 2003;43:219–231.CrossRefGoogle Scholar
  16. 16.
    Chapin RE, Ku WW, Kenney MA, McCoy H. The effects of dietary boric acid on bone strength in rats. Biol Trace Elem Res. 1998;66:395–9.CrossRefGoogle Scholar
  17. 17.
    Uysal T, Ustdal A, Sonmez MF, Ozturk F. Stimulation of bone formation by dietary boron in an orthopedically expanded suture in rabbits. Angle Orthod. 2009;79:984–90.CrossRefGoogle Scholar
  18. 18.
    De Seta F, Schmidt M, Vu B, Essmann M, Larsen B. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. J Antimicrob Chemother. 2008;63:325–36.CrossRefGoogle Scholar
  19. 19.
    Qin G, Zong Y, Chen Q, Hua D, Tian S. Inhibitory effect of boron against Botrytis cinerea on table grapes and its possible mechanisms of action. Int J Food Microbiol. 2010;138:145–50.CrossRefGoogle Scholar
  20. 20.
    Wu C, Miron R, Sculean A, Kaskel S, Doert T, Schulze R, et al. Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds. Biomaterials. 2011;32:7068–78.CrossRefGoogle Scholar
  21. 21.
    Durand LAH, Vargas GE, Romero NM, Vera-Mesones R, Porto-López JM, Boccaccini AR, et al. Angiogenic effects of ionic dissolution products released from a boron-doped 45S5 bioactive glass. J Mater Chem B. 2015;3:1142–8.CrossRefGoogle Scholar
  22. 22.
    Seyedmomeni SS, Naeimi M, Raz M, Mohandesi JA, Moztarzadeh F, Baghbani F, et al. Synthesis, characterization and biological evaluation of a new sol-gel derived B and Zn-containing bioactive glass: in vitro study. Silicon. 2018;10:197–203.Google Scholar
  23. 23.
    Balasubramanian P, Hupa L, Jokic B, Detsch R, Grünewald A, Boccaccini AR. Angiogenic potential of boron-containing bioactive glasses: in vitro study. J Mater Sci. 2017;52:8785–92.CrossRefGoogle Scholar
  24. 24.
    El-Kady AM, Farag MM, El-Rashedi AM. Bioactive glass nanoparticles designed for multiple deliveries of lithium ions and drugs: curative and restorative bone treatment. Eur J Pharm Sci. 2016;91:243–50.CrossRefGoogle Scholar
  25. 25.
    Shruti S, Salinas AJ, Ferrari E, Malavasi G, Lusvardi G, Doadrio AL, et al. Curcumin release from cerium, gallium and zinc containing mesoporous bioactive glasses. Microporous Mesoporous Mater. 2013;180:92–101.CrossRefGoogle Scholar
  26. 26.
    Zhang Y, Wang X, Su Y, Chen D, Zhong W. A doxorubicin delivery system: samarium/mesoporous bioactive glass/alginate composite microspheres. Mater Sci. Eng C Mater Biol. Appl. 2016;67:205–13.CrossRefGoogle Scholar
  27. 27.
    Lee J-H, Mandakhbayar N, El-Fiqi A, Kim H-W. Intracellular co-delivery of Sr ion and phenamil drug through mesoporous bioglass nanocarriers synergizes BMP signaling and tissue mineralization. Acta Biomater. 2017;60:93–108.CrossRefGoogle Scholar
  28. 28.
    Xue Y, Du Y, Yan J, Liu Z, Ma PX, Chen X, et al. Monodisperse photoluminescent and highly biocompatible bioactive glass nanoparticles for controlled drug delivery and cell imaging. J Mater Chem B. 2015;3:3831–9.CrossRefGoogle Scholar
  29. 29.
    Singh R, Singh S. Role of phosphate on stability and catalase mimetic activity of cerium oxide nanoparticles. Colloids Surf B Biointerfaces. 2015;132:78–84.CrossRefGoogle Scholar
  30. 30.
    Singh S, Dosani T, Karakoti AS, Kumar A, Seal S, Self WT. A phosphate-dependent shift in redox state of cerium oxide nanoparticles and its effects on catalytic properties. Biomaterials. 2011;32:6745–53.CrossRefGoogle Scholar
  31. 31.
    Xia W, Chang J. Preparation and characterization of nano-bioactive-glasses (NBG) by a quick alkali-mediated sol–gel method. Mater Lett. 2007;61:3251–3.CrossRefGoogle Scholar
  32. 32.
    Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006;27:2907–15.CrossRefGoogle Scholar
  33. 33.
    Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.CrossRefGoogle Scholar
  34. 34.
    MacFaddin J. Media for isolation-cultivation-identification-maintenance of medical bacteria. Vol. 1, Williams and Wilkins: Baltimore; 1985.Google Scholar
  35. 35.
    Lapage S, Shelton J, Mitchell T. Methods in microbiology. Academic Press, London, 1970;3A.Google Scholar
  36. 36.
    Clesceri L, Greenberg A, Eaton A. Standard methods for the examination of water and wastewater, American Public Health Association (APHA), American Water Works Association, Water Environment Federation, Washington, DC. Standard methods for the examination of water and wastewater, 20th ed American Public Health Association (APHA), American Water Works Association, Water Environment Federation, Washington, DC. 1998.Google Scholar
  37. 37.
    Barry A. Procedure for testing antimicrobial agents in agar media: theoretical considerations. Antibiot Lab Med. 1986;2:1–26.Google Scholar
  38. 38.
    Rahman MU, Gul S, Haq MZU. Reduction of chromium (VI) by locally isolated Pseudomonas sp. C-171. Turk J Biol. 2007;31:161–6.Google Scholar
  39. 39.
    Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK. Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm. 2008;68:513–25.Google Scholar
  40. 40.
    Higuchi T. Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–9.CrossRefGoogle Scholar
  41. 41.
    Ashuri M, Moztarzadeh F, Nezafati N, Hamedani AA, Tahriri M. Development of a composite based on hydroxyapatite and magnesium and zinc‐containing sol–gel-derived bioactive glass for bone substitute applications. Mater Sci Eng C. 2012;32:2330–9.CrossRefGoogle Scholar
  42. 42.
    Saboori A, Rabiee M, Moztarzadeh F, Sheikhi M, Tahriri M, Karimi M. Synthesis, characterization and in vitro bioactivity of sol-gel-derived SiO2–CaO–P2O5–MgO bioglass. Mater Sci Eng C. 2009;29:335–40.CrossRefGoogle Scholar
  43. 43.
    Goh Y-F, Alshemary AZ, Akram M, Kadir MRA, Hussain R. In vitro study of nano-sized zinc doped bioactive glass. Mater Chem Phys. 2013;137:1031–8.CrossRefGoogle Scholar
  44. 44.
    Montazerian M, Schneider JF, Yekta BE, Marghussian VK, Rodrigues AM, Zanotto ED. Sol–gel synthesis, structure, sintering and properties of bioactive and inert nano-apatite–zirconia glass–ceramics. Ceram Int. 2015;41:11024–45.CrossRefGoogle Scholar
  45. 45.
    Aguiar H, Solla E, Serra J, González P, León B, Almeida N, et al. Orthophosphate nanostructures in SiO 2–P 2 O 5–CaO–Na 2 O–MgO bioactive glasses. J Non-Cryst Solids. 2008;354:4075–80.CrossRefGoogle Scholar
  46. 46.
    Zhang E, Zou C, Yu G. Surface microstructure and cell biocompatibility of silicon-substituted hydroxyapatite coating on titanium substrate prepared by a biomimetic process. Mater Sci Eng C. 2009;29:298–305.CrossRefGoogle Scholar
  47. 47.
    Deliormanlı AM, Yıldırım M. Sol-gel synthesis of 13-93 bioactive glass powders containing therapeutic agents. J Aust Ceram Soc Vol. 2016;52:9–19.Google Scholar
  48. 48.
    Oliveira J, Correia R, Fernandes M. Effects of Si speciation on the in vitro bioactivity of glasses. Biomaterials. 2002;23:371–9.CrossRefGoogle Scholar
  49. 49.
    Hesaraki S, Gholami M, Vazehrad S, Shahrabi S. The effect of Sr concentration on bioactivity and biocompatibility of sol–gel derived glasses based on CaO–SrO–SiO2–P2O5 quaternary system. Mater Sci Eng C. 2010;30:383–90.CrossRefGoogle Scholar
  50. 50.
    Kokubo T, Ito S, Huang Z, Hayashi T, Sakka S, Kitsugi T, et al. Ca, P‐rich layer formed on high‐strength bioactive glass‐ceramic A‐W. J Biomed Mater Res A. 1990;24:331–43.CrossRefGoogle Scholar
  51. 51.
    Absher M, Mortara M. Effect of silica on the proliferative behavior of human lung fibroblasts. In Vitro Cell Dev Biol Plant. 1980;16:371–6.CrossRefGoogle Scholar
  52. 52.
    Uivarosi V. Metal complexes of quinolone antibiotics and their applications: an update. Molecules. 2013;18:11153–97.CrossRefGoogle Scholar
  53. 53.
    Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48:5–16.CrossRefGoogle Scholar
  54. 54.
    Xu C, Qu X. Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia. Materials. 2014;6:e90.Google Scholar
  55. 55.
    Celardo I, Pedersen JZ, Traversa E, Ghibelli L. Pharmacological potential of cerium oxide nanoparticles. Nanoscale. 2011;3:1411–20.CrossRefGoogle Scholar
  56. 56.
    Montero MT, Pijoan M, Merino-Montero S, Vinuesa T, Hernández-Borrell J. Interfacial membrane effects of fluoroquinolones as revealed by a combination of fluorescence binding experiments and atomic force microscopy observations. Langmuir. 2006;22:7574–8.CrossRefGoogle Scholar
  57. 57.
    Grancelli A, Morros A, Cabañas ME, Domènech Ò, Merino S, Vázquez JL, et al. Interaction of 6-fluoroquinolones with dipalmitoylphosphatidylcholine monolayers and liposomes. Langmuir. 2002;18:9177–82.CrossRefGoogle Scholar
  58. 58.
    Fresta M, Guccione S, Beccari AR, Furneri PM, Puglisi G. Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin. Bioorg Med Chem. 2002;10:3871–89.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Glass Research DepartmentNational Research CentreDokkiEgypt
  2. 2.Refractories, Ceramics and Building Materials DepartmentNational Research CentreDokkiEgypt

Personalised recommendations